These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors: initial functional and oncologic outcomes. Yang R; Lian H; Zhang G; Wang W; Gan W; Li X; Yan X; Zhang S; Zhao X; Guo H J Endourol; 2014 Jan; 28(1):4-9. PubMed ID: 23998802 [TBL] [Abstract][Full Text] [Related]
45. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease. Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786 [TBL] [Abstract][Full Text] [Related]
46. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors. Dai Y; Covarrubias D; Uppot R; Arellano RS J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657 [TBL] [Abstract][Full Text] [Related]
47. Ablative techniques: Radiofrequency and cryotherapy, which is the best? Lusch A; Graversen JA; Liss MA; Landman J Arch Esp Urol; 2013; 66(1):71-8. PubMed ID: 23406802 [TBL] [Abstract][Full Text] [Related]
49. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Su Li; Jarrett TW; Chan DY; Kavoussi LR; Solomon SB Urology; 2003 Apr; 61(4 Suppl 1):26-33. PubMed ID: 12657358 [TBL] [Abstract][Full Text] [Related]
50. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies. El Dib R; Touma NJ; Kapoor A BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329 [TBL] [Abstract][Full Text] [Related]
51. Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications. del Cura JL; Zabala R; Iriarte JI; Unda M Eur Urol; 2010 Mar; 57(3):459-65. PubMed ID: 19926208 [TBL] [Abstract][Full Text] [Related]
57. Efficacy of imaging-guided percutaneous radiofrequency ablation for the treatment of biopsy-proven malignant cystic renal masses. Felker ER; Lee-Felker SA; Alpern L; Lu D; Raman SS AJR Am J Roentgenol; 2013 Nov; 201(5):1029-35. PubMed ID: 24147473 [TBL] [Abstract][Full Text] [Related]
58. Ablation of small renal masses: practice patterns at academic institutions in the United States. Patel SR; Abel EJ; Hedican SP; Nakada SY J Endourol; 2013 Feb; 27(2):158-61. PubMed ID: 22974005 [TBL] [Abstract][Full Text] [Related]
59. Predictive factors for complete renal tumor ablation using RFA. Acosta Ruiz V; Lönnemark M; Brekkan E; Dahlman P; Wernroth L; Magnusson A Acta Radiol; 2016 Jul; 57(7):886-93. PubMed ID: 26452975 [TBL] [Abstract][Full Text] [Related]